AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other Medicines (Established / Legacy Brands) by Year
Other Medicines (Established / Legacy Brands) — Established RoW product sales ($M) ($M)
AstraZeneca Other Medicines (Established / Legacy Brands): $93M in FY2025, down 25.0% from a year earlier.
Where the FY2025 figure comes from
“|| Other Medicines | 972 | (9) | (8) | 63 | (43) | 732 | - | 1 | 84 | (19) | (20) | 93 | (25) | (24)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Therapy Area Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Medicines (Established / Legacy Brands) — Established RoW product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 93 | -25.0% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 124 | -40.1% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 207 | -63.7% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 570 | -4.4% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 596 | +12.5% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 530 | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Breakdown
What makes up other Medicines (Established / Legacy Brands)
Cite this data
StockData. (2026). AstraZeneca Other Medicines (Established / Legacy Brands) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-other-meds-erow
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.